{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:50:49Z","timestamp":1792403449920,"version":"4.4.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/bjd.18220","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T13:09:01Z","timestamp":1560776941000},"page":"316-326","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["<scp>AURIEL<\/scp>\n                    \u2010PsO: a randomized, double\u2010blind phase\n                    <scp>III<\/scp>\n                    equivalence trial to demonstrate the clinical similarity of the proposed biosimilar\n                    <scp>MSB<\/scp>\n                    11022 to reference adalimumab in patients with moderate\u2010to\u2010severe chronic plaque\u2010type psoriasis"],"prefix":"10.1093","volume":"182","author":[{"given":"J.","family":"Hercogov\u00e1","sequence":"first","affiliation":[{"name":"Dermatology Department 2nd Medical Faculty Charles University and Na Bulovce Hospital Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9557-3642","authenticated-orcid":false,"given":"K.A.","family":"Papp","sequence":"additional","affiliation":[{"name":"K Papp Clinical Research and Probity Medical Research Inc. Waterloo ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chyrok","sequence":"additional","affiliation":[{"name":"Fresenius Kabi Eysin Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ullmann","sequence":"additional","affiliation":[{"name":"Fresenius Kabi Eysin Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vlachos","sequence":"additional","affiliation":[{"name":"Cytel Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Edwards","sequence":"additional","affiliation":[{"name":"NIHR Clinical Research Facility University of Southampton Southampton U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1090051"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.01.002"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/03946320140270S103"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203819"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2017.1345580"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0230-9"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14267"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15067"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15756"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0881-y"},{"key":"e_1_2_6_12_1","unstructured":"European Medicines Agency.Guideline on similar biological medicinal products containing biotechnology\u2010derived proteins as active substance: non\u2010clinical and clinical issues. Available at:https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-similar-biological-medicinal-products-containing-biotechnology-derived-proteins-active_en-2.pdf(last accessed 18 July 2019)."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1259046"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13039"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000083509"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.865009"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.87802"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1743-2"},{"issue":"5","key":"e_1_2_6_23_1","first-page":"S14","article-title":"The Health Assessment Questionnaire (HAQ)","volume":"23","author":"Bruce B","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100857"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11214.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09950.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09893.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.08.040"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02288.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.03161.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.09.040"},{"key":"e_1_2_6_32_1","first-page":"864","article-title":"Efficacy of adalimumab compared with methotrexate or placebo stratified by baseline BMI in a randomized placebo\u2010controlled trial in patients with psoriasis","volume":"14","author":"Prussick R","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09791.x"},{"issue":"21","key":"e_1_2_6_34_1","first-page":"S403","article-title":"Contemporary management of moderate to severe plaque psoriasis","volume":"23","author":"Wu JJ","year":"2017","journal-title":"Am J Manag Care"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00748.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13746"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15857"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2278"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501646"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.027"},{"key":"e_1_2_6_41_1","unstructured":"AbbVie Inc.Prescribing information: HUMIRA (adalimumab) injection for subcutaneous use. Available at:http:\/\/www.rxabbvie.com\/pdf\/humira.pdf(last accessed 18 July 2019)."},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3072586"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13112"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.5479"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16890"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40444"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208786"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.18220","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18220","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.18220","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:50:42Z","timestamp":1676364642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/182\/2\/316\/6753143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/bjd.18220"],"URL":"https:\/\/doi.org\/10.1111\/bjd.18220","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"2019-06-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}